Bionano Genomics Inc.
Organization details
- Legal name
- Bionano Genomics Inc.
- Former names
- BioNanomatrix Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Information Technology
- SIC code
- 3826 — Laboratory Analytical Instruments
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BNGO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001411690
- EIN
- 26-1756290
Board of directors
-
Albert Luderer · Director · Interim Chief ExecutiveSince 2023
-
Aleksandar Rajkovic · DirectorSince 2023
-
Christopher J. Twomey · DirectorSince 2023
-
David L. Barker · DirectorSince 2023
-
Hannah Mamuszka · DirectorSince 2023
-
Kristiina Vuori M.D. · DirectorSince 2023
-
R. Erik Holmlin · Director · PRESIDENT AND CEOSince 2023
-
Vincent Jung-Fai Wong · DirectorSince 2023
-
Yvonne Linney · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.5%
-
87.5%
Board connections
2 of this board's directors also sit on 2 other boards.
- via Kristiina Vuori M.D.
- via Christopher J. Twomey
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $9,720
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Albert Luderer Director, Officer (Interim Chief Executive) | Open-market purchase | +4,000 | $1.21 | $4,840 |
| Aug 21, 2026 | Albert Luderer Director, Officer (Interim Chief Executive) | Open-market purchase | +4,000 | $1.22 | $4,880 |
| Jun 3, 2026 | Dixon Jonathan V. Officer (GENERAL COUNSEL) | Shares withheld for tax | −24 | $1.30 | $31 |
| Jun 3, 2026 | OLDAKOWSKI MARK Officer (CHIEF OPERATING OFFICER) | Shares withheld for tax | −27 | $1.30 | $35 |
| Jun 3, 2026 | Chaubey Alka Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −24 | $1.30 | $31 |
| Jun 3, 2026 | Adamchak Mark Officer (Principal Accounting Officer) | Shares withheld for tax | −7 | $1.30 | $9 |
| Feb 17, 2026 | Chaubey Alka Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −18 | $1.10 | $20 |
| Feb 17, 2026 | Adamchak Mark Officer (Principal Accounting Officer) | Shares withheld for tax | −3 | $1.10 | $3 |
| Feb 17, 2026 | Dixon Jonathan V. Officer (GENERAL COUNSEL) | Shares withheld for tax | −6 | $1.10 | $7 |
| Feb 17, 2026 | OLDAKOWSKI MARK Officer (CHIEF OPERATING OFFICER) | Shares withheld for tax | −20 | $1.10 | $22 |
| Feb 17, 2026 | R. Erik Holmlin Director, Officer (PRESIDENT AND CEO) | Shares withheld for tax | −51 | $1.10 | $56 |
| Sep 11, 2025 | OLDAKOWSKI MARK Officer (Chief Operating Officer) | Shares withheld for tax | −59 | $4.06 | $240 |
| Sep 11, 2025 | Chaubey Alka Officer (Chief Medical Officer) | Shares withheld for tax | −51 | $4.06 | $207 |
| Jun 3, 2025 | OLDAKOWSKI MARK Officer (Chief Operating Officer) | Shares withheld for tax | −27 | $3.69 | $100 |
| Jun 3, 2025 | Adamchak Mark Officer (Principal Accounting Officer) | Shares withheld for tax | −7 | $3.69 | $26 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Bionano Genomics Inc.
Who is the CEO of Bionano Genomics Inc.?
R. Erik Holmlin is Bionano Genomics Inc.'s President and CEO.
How many directors are on Bionano Genomics Inc.'s board?
Bionano Genomics Inc.'s board has 9 directors: Albert Luderer, Aleksandar Rajkovic, Christopher J. Twomey, David L. Barker, Hannah Mamuszka, Kristiina Vuori M.D., R. Erik Holmlin, Vincent Jung-Fai Wong and Yvonne Linney.
Are Bionano Genomics Inc. insiders buying or selling shares?
Over the last 12 months, Bionano Genomics Inc. insiders bought $9,720 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="bionano-genomics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.